An Explorative Analysis of <i>ABCG2/TOP-1</i> mRNA Expression as a Biomarker Test for FOLFIRI Treatment in Stage III Colon Cancer Patients: Results from Retrospective Analyses of the PETACC-3 Trial.

Stenvang, Jan; Budinská, Eva; van Cutsem, Eric; Bosman, Fred; Popovici, Vlad; Brünner, Nils

An Explorative Analysis of ABCG2/TOP-1 mRNA Expression as a Biomarker Test for FOLFIRI Treatment in Stage III Colon Cancer Patients: Results from Retrospective Analyses of the PETACC-3 Trial.

Stenvang, Jan; Budinská, Eva; van Cutsem, Eric; Bosman, Fred; Popovici, Vlad; Brünner, Nils.

Afiliação

Stenvang J; Section of Molecular Disease Biology, Institute of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, 2100 Copenhagen, Denmark.
Budinská E; Scandion Oncology, Symbion, 2100 Copenhagen, Denmark.
van Cutsem E; RECETOX, Faculty of Science, Masarykova Univerzita, 625 00 Brno, Czech Republic.
Bosman F; Digestive Oncology Department, University Hospitals Leuven and KU Leuven, 3001 Leuven, Belgium.
Popovici V; University Institute of Pathology, University of Lausanne, 1011 Lausanne, Switzerland.
Brünner N; RECETOX, Faculty of Science, Masarykova Univerzita, 625 00 Brno, Czech Republic.

Cancers (Basel) ; 12(4)2020 Apr 15.

Article em En | MEDLINE | ID: mdl-32326511

Palavras-chave

ABCG2; TOP-1; adjuvant irinotecan; biomarkers; colon cancer

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Dinamarca País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google